Marksans Pharma Limited
MARKSANS

Marksans Pharma Limited

Healthcare
Share price
321
Market cap
₹14,558 Cr
1Y return
78%

A pharmaceutical formulation company engaged in the development and manufacture of a diverse range of drugs across multiple therapeutic areas for domestic and international markets. Marksans Pharma produces generic medications and branded formulations with a focus on quality and regulatory compliance. The company operates modern manufacturing facilities designed to meet stringent pharmaceutical production standards and global quality requirements.

Latest move

Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Marksans Pharma from 1.13% to 1.14%, buying 20,101 shares for ₹53.69 lakh at ₹267.10 apiece.
20 Jul 2026Sign in to read more

Whales made 1 more move in Marksans Pharma Limited

Sign in to see who is buying and selling.

Sign in to find out
Marksans Pharma — investor holdings · WhaleWatch